Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. AnaptysBio
FDA Inspection
•AnaptysBio•April 29, 2026

AnaptysBio – FDA Inspection, Apr 29, 2026

Record Details

This FDA Inspection record concerns AnaptysBio, with an inspection on April 29, 2026, issued by the Los Angeles District Office, covering human drugs.

Company
AnaptysBio
Inspection Date
April 29, 2026
Product Type
Human Drugs
Office
Los Angeles District Office
Person
  • Farwa Z. Razvi (Company Rep)
View Company Profile

ID · 97589b7c-1fe1-4a22-af67-9c1f29711d4d

Inspection Facts

Inspection number
1315526
FDA center
Human Drugs
Project area
Bioresearch Monitoring
Outcome
Form 483 issued, view the record

FDA Citations

1
  1. 21 CFR 312.50General responsibilities of sponsors

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore AnaptysBio
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.